Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Trehalose-6,6'-dibehenate

Trehalose-6,6'-dibehenate is an orally active glycolipid. Trehalose-6,6'-dibehenate activates Mincle and inflammasome, inducing IL-1β secretion in a caspase activity-dependent manner. Trehalose-6,6'-dibehenate exerts a Myd88-dependent adjuvant activity. Trehalose-6,6'-dibehenate induces Th-1/Th-17 immune responses[1][2][3][4][5].

Product Specifications

CAS Number

[66758-35-8]

UNSPSC

12352208

Hazard Statement

H302, H315, H319

Target

Caspase; Interleukin Related; MyD88

Type

Reference compound

Related Pathways

Apoptosis; Immunology/Inflammation

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/trehalose-6-6-dibehenate.html

Purity

99.92

Solubility

DMF : 0.5 mg/mL (ultrasonic; warming; heat to 60°C)

Smiles

CCCCCCCCCCCCCCCCCCCCCC(OC[C@H]([C@H]([C@@H]([C@H]1O)O)O)O[C@@H]1O[C@H]2O[C@@H]([C@H]([C@@H]([C@H]2O)O)O)COC(CCCCCCCCCCCCCCCCCCCCC)=O)=O

Molecular Formula

C56H106O13

Molecular Weight

987.43

Precautions

H302, H315, H319

References & Citations

[1]Yu H, et, al. Chlamydia muridarum T-cell antigens formulated with the adjuvant DDA/TDB induce immunity against infection that correlates with a high frequency of gamma interferon (IFN-gamma) /tumor necrosis factor alpha and IFN-gamma/interleukin-17 double-positive CD4+ T cells. Infect Immun. 2010 May;78 (5) :2272-82. |[2]Schweneker K, et al. The mycobacterial cord factor adjuvant analogue trehalose-6,6'-dibehenate (TDB) activates the Nlrp3 inflammasome. Immunobiology. 2013 Apr;218 (4) :664-73.|[3]Althaus K. Mechanism of the adjuvant activity of the synthetic mycobacterial cord factor analog Trehalose-6, 6-dibehenate (TDB) . Technische Universität München, 2010. |[4]Davidsen J, et al. Characterization of cationic liposomes based on dimethyldioctadecylammonium and synthetic cord factor from M. tuberculosis (trehalose 6,6'-dibehenate) -a novel adjuvant inducing both strong CMI and antibody responses. Biochim Biophys Acta. 2005 Dec 10;1718 (1-2) :22-31.|[5]Ruizhi T A N, et al. Chaihuang Yishen Granules Improves Renal Fibrosis in Mice with Chronic Kidney Disease by Inhibiting Macrophagic Mincle. Traditional Chinese Drug Research & Clinical Pharmacology, 2023: 1658-1667.

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Scientific Category

Reference compound1

Clinical Information

Phase 3

Available Sizes

More Discoveries

Explore Other Products

Browse additional items from our catalog

MIRacle™ mmu-miR-3473b miRNA Agomir/Antagomir
AM3745 2 OD, 4 OD, 50 OD

MIRacle™ mmu-miR-3473b miRNA Agomir/Antagomir

Sign In for Pricing
View Details
TE-Buffer 100X pH 7.4
42020306-2 1 L

TE-Buffer 100X pH 7.4

Sign In for Pricing
View Details
Recombinant Rat IL-1 beta/ IL1B Protein, Untagged, E.coli-500ug
QP5516-500ug 500ug

Recombinant Rat IL-1 beta/ IL1B Protein, Untagged, E.coli-500ug

Sign In for Pricing
View Details
FITC-Linked Polyclonal Antibody to Very Low Density Lipoprotein Receptor (VLDLR)
MBS2050422-01 0.1 mL

FITC-Linked Polyclonal Antibody to Very Low Density Lipoprotein Receptor (VLDLR)

Sign In for Pricing
View Details
FITC-Linked Polyclonal Antibody to Very Low Density Lipoprotein Receptor (VLDLR)
MBS2050422-02 0.2 mL

FITC-Linked Polyclonal Antibody to Very Low Density Lipoprotein Receptor (VLDLR)

Sign In for Pricing
View Details
FITC-Linked Polyclonal Antibody to Very Low Density Lipoprotein Receptor (VLDLR)
MBS2050422-03 0.5 mL

FITC-Linked Polyclonal Antibody to Very Low Density Lipoprotein Receptor (VLDLR)

Sign In for Pricing
View Details